中国医药

- 600056

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2026  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
中国医药(600056) 利润表
单位:万元
报表日期2026-06-302026-03-312025-12-312025-09-302025-06-30
一、营业总收入1,695,192.49818,878.013,536,162.172,589,443.511,707,586.01
营业收入1,695,192.49818,878.013,536,162.172,589,443.511,707,586.01
二、营业总成本1,637,255.03787,978.923,411,238.772,498,322.181,643,827.95
营业成本1,511,039.41731,997.053,164,784.722,320,363.691,529,424.60
营业税金及附加5,290.482,413.1110,392.797,454.295,343.44
销售费用43,872.0419,853.35101,453.2875,947.7049,467.67
管理费用56,430.4027,313.16107,768.7980,842.1554,006.89
财务费用12,527.762,944.2511,001.633,501.35-977.55
研发费用8,094.943,458.0015,837.5610,213.006,562.90
资产减值损失----------
公允价值变动收益-----221.05589.10589.10
投资收益1,252.66761.53-6,801.021,289.95945.69
其中:对联营企业和合营企业的投资收益3,492.231,902.153,136.714,138.892,874.57
汇兑收益----------
三、营业利润47,789.6131,274.00102,298.8282,376.2652,487.02
加:营业外收入1,254.57373.112,702.131,034.97468.37
减:营业外支出1,010.35216.335,071.471,166.47883.15
其中:非流动资产处置损失----------
四、利润总额48,033.8231,430.7899,929.4882,244.7752,072.24
减:所得税费用16,811.797,716.8332,465.9023,373.7014,539.53
五、净利润31,222.0323,713.9567,463.5858,871.0737,532.71
归属于母公司所有者的净利润24,911.1318,219.7147,322.9145,476.3929,395.94
少数股东损益6,310.905,494.2420,140.6813,394.688,136.77
六、每股收益
基本每股收益(元/股)0.16650.12180.31640.30400.1965
稀释每股收益(元/股)0.16650.12180.31640.30400.1965
七、其他综合收益57.39-152.59-838.7861.40262.88
八、综合收益总额31,279.4323,561.3666,624.8058,932.4737,795.59
归属于母公司所有者的综合收益总额24,950.1618,067.1246,471.7945,537.7929,658.82
归属于少数股东的综合收益总额6,329.275,494.2420,153.0113,394.688,136.77
下载全部历史数据到excel中 ↑返回页顶↑